Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX7 | Q99572 | 5/20 | 0.43 |
| ▸ | CD38 | P28907 | 1/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.34 |
| ▸ | AURKA | O14965 | 1/20 | 0.33 |
| ▸ | RPS6KB1 | P23443 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | ELANE | P08246 | 1/20 | 0.32 |
| ▸ | VCP | P55072 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6686286 | 0.92 | P2RX7 (0.43) | P2RX7MEN1KMT2A | |
| SCHEMBL6658009 | 0.91 | P2RX7 (0.42) | P2RX7AURKARPS6KB1MEN1KMT2A | |
| SCHEMBL6651560 | 0.89 | P2RX7 (0.43) | P2RX7CHRM2MEN1KMT2A | |
| SCHEMBL6655499 | 0.87 | P2RX7 (0.42) | P2RX7AURKARPS6KB1VCP | |
| SCHEMBL6653472 | 0.87 | P2RX7 (0.45) | P2RX7 | |
| SCHEMBL6653481 | 0.84 | P2RX7 (0.45) | P2RX7 | |
| SCHEMBL6647801 | 0.82 | P2RX7 (0.52) | P2RX7 | |
| SCHEMBL6651900 | 0.81 | P2RX7 (0.47) | P2RX7 | |
| Hydrochloric Acid SCHEMBL6674326 | 0.81 | P2RX7 (0.60) | P2RX7 | |
| SCHEMBL6655639 | 0.80 | P2RX7 (0.45) | P2RX7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1490341-A1 | NOVEL ADAMANTANE DERIVATIVES | AstraZeneca AB (SE) | 2004-12-29 | — | — | EP | disclosed |
| WO-2003080579-A1 | NOVEL ADAMANTANE DERIVATIVES | ASTRAZENECA AB (SE) | 2003-10-02 | — | — | WO | disclosed |